Mar 11, 2021Nuvation Bio Granted Orphan Drug Designation for NUV-422 for Patients with Malignant GliomasNEW YORK, March 11, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet...
Mar 11, 2021Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early TreatIndependent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or...